Exact Sciences Corp (NAS:EXAS)
$ 49.84 -4.24 (-7.84%) Market Cap: 9.20 Bil Enterprise Value: 11.10 Bil PE Ratio: 0 PB Ratio: 2.93 GF Score: 80/100

Exact Sciences Corp at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript

May 13, 2020 / 01:00PM GMT
Release Date Price: $84.59 (+1.49%)
Derik De Bruin
BofA Merrill Lynch, Research Division - MD of Equity Research

Good morning, everyone. This is Derik De Bruin, the Bank of America Life Sciences and Diagnostic Tools Analyst. Welcome to our Virtual Vegas Health Care Conference. We appreciate everyone being here today. Our next speaker today is -- presentation today is Exact Sciences. Here, we have Kevin Conroy for the company, CEO of the company, here with us to sort of update us on what's going on at Exact and the exciting world of colon cancer screening and now COVID testing. Kevin, welcome.

Kevin T. Conroy
Exact Sciences Corporation - Chairman of the Board, President & CEO

Thank you, Derik. Great to be here.

Derik De Bruin
BofA Merrill Lynch, Research Division - MD of Equity Research

Remember everybody, you can chat me questions. If you're dialed into Veracast line, please feel happy to do it.

Questions & Answers

Derik De Bruin
BofA Merrill Lynch, Research Division - MD of Equity Research

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot